SPARE-Tau was trained on tau SUVRs to predict clinical status (CU vs MCI/AD) while AD-RAI was trained on T1-weighted MRI volumetric measures also to predict clinical status and quantify brain atrophy. This evidence concerns the gene MAPT and Brain atrophy.